Arcaini, L

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jul 2008 - 1331-1335 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1569-8041

10.1093/annonc/mdn044 doi


Adult
Anthracyclines--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20--metabolism
Antigens, CD34--analysis
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bleomycin--administration & dosage
Bone Marrow Purging--methods
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Disease Progression
Disease-Free Survival
Doxorubicin--administration & dosage
Drug Administration Schedule
Etoposide--administration & dosage
Female
Follow-Up Studies
Genes, bcl-2
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematopoietic Stem Cell Mobilization
Humans
Immunologic Factors--administration & dosage
Immunosuppressive Agents--administration & dosage
Kaplan-Meier Estimate
Lymphoma, Follicular--drug therapy
Male
Middle Aged
Multivariate Analysis
Peripheral Blood Stem Cell Transplantation
Recurrence
Remission Induction
Rituximab
Time Factors
Transplantation, Autologous
Treatment Outcome
Vincristine--administration & dosage